Cargando…

Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway

BACKGROUND: Parecoxib plays an important role in inhibition of human cancer. However, the effect of parecoxib on esophageal squamous cell carcinoma (ESCC) is still not well known. The purpose of this study was to investigate the effect of parecoxib on ESCC and its underlying mechanism. METHODS: RNA-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Han-Ming, Huang, Xiao-Yu, Wu, Shao-Ping, Chen, Can-Keng, He, Xin-Hua, Zhang, Yong-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933956/ https://www.ncbi.nlm.nih.gov/pubmed/35305553 http://dx.doi.org/10.1186/s11658-022-00324-w

Ejemplares similares

Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway
por: Huang, Han-Ming, et al.
Publicado: (2022)

RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway
por: Huang, Han-Ming, et al.
Publicado: (2022)

Retraction Note: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway
por: Huang, Han-Ming, et al.
Publicado: (2023)

PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
por: Pai, Shin, et al.
Publicado: (2021)

Inhibition of MUC1‐C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma
por: GongSun, Xin, et al.
Publicado: (2018)

Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma
por: Lu, Juan, et al.
Publicado: (2018)

lncRNA‐PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway
por: Pan, Weidong, et al.
Publicado: (2019)

Multimodal Analgesia with Local Wound Infiltration and Intravenous Parecoxib for Thyroidectomy
por: Gau, Tz-Ping, et al.
Publicado: (2023)

Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR-9
por: Sheng, Wen, et al.
Publicado: (2021)

Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
por: Lin, H-J, et al.
Publicado: (2005)

MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression By Targeting PDK1/PI3K/AKT Pathway
por: Wei, Yingying, et al.
Publicado: (2019)

Analgesic effect of parecoxib combined with ropivacaine in patients undergoing laparoscopic hepatectomy
por: Huang, Shan-Shan, et al.
Publicado: (2019)

MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1
por: Mao, Yu, et al.
Publicado: (2016)

The oncogenic and prognostic role of PDK1 in the progression and metastasis of ovarian cancer
por: Yao, Shasha, et al.
Publicado: (2021)

Cooperative activation of PDK1 and AKT by MAPK4 enhances cancer growth and resistance to therapy
por: Han, Dong, et al.
Publicado: (2023)

Naomaitai Ameliorated Brain Damage in Rats with Vascular Dementia by PI3K/PDK1/AKT Signaling Pathway
por: Huang, Kui, et al.
Publicado: (2019)

Indoprofen prevents muscle wasting in aged mice through activation of PDK1/AKT pathway
por: Kim, Hyebeen, et al.
Publicado: (2020)

Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway
por: Han, Fei, et al.
Publicado: (2017)

Withdrawn: Parecoxib inhibits inflammatory responses in a mouse model of sepsis
Publicado: (2021)

A Novel PDK1/MEK Dual Inhibitor Induces Cytoprotective Autophagy via the PDK1/Akt Signaling Pathway in Non-Small Cell Lung Cancer
por: Liu, Rangru, et al.
Publicado: (2023)

Pretreatment of parecoxib attenuates hepatic ischemia/reperfusion injury in rats
por: Zhang, Tao, et al.
Publicado: (2015)

Analgesic Effects of Intra-Articular Bupivacaine/Intravenous Parecoxib Combination Therapy versus Intravenous Parecoxib Monotherapy in Patients Receiving Total Knee Arthroplasty: A Randomized, Double-Blind Trial
por: Shen, Shih-Jyun, et al.
Publicado: (2015)

Baicalin Inhibits EMT through PDK1/AKT Signaling in Human Nonsmall Cell Lung Cancer
por: Chen, Jia, et al.
Publicado: (2021)

Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)

Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum
por: Han, Fei, et al.
Publicado: (2020)

Spatial alterations of De Novo purine biosynthetic enzymes by Akt-independent PDK1 signaling pathways
por: Schmitt, Danielle L., et al.
Publicado: (2018)

Effect of parecoxib in the treatment of postoperative cognitive dysfunction: A systematic review and meta-analysis
por: Huang, Song, et al.
Publicado: (2019)

Paclitaxel-induced lung injury and its amelioration by parecoxib sodium
por: Liu, Wen-jie, et al.
Publicado: (2015)

PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound
por: Cen, L, et al.
Publicado: (2007)

CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency
por: Wang, Xiao Qi, et al.
Publicado: (2017)

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway
por: Qiao, Zhongshi, et al.
Publicado: (2022)

Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway
por: ZHANG, HONG-BO, et al.
Publicado: (2013)

CaMKK2 Promotes the Progression of Ovarian Carcinoma through the PI3K/PDK1/Akt Axis
por: Chen, Zhen, et al.
Publicado: (2022)

SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling
por: Zhang, Aijia, et al.
Publicado: (2019)

SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway
por: Ren, Chunhong, et al.
Publicado: (2021)

ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway
por: Huang, Wei, et al.
Publicado: (2021)

MicroRNA-206 exerts anti-oncogenic functions in esophageal squamous cell carcinoma by suppressing the c-Met/AKT/mTOR pathway
por: Zhang, Jin, et al.
Publicado: (2019)

Neurofilament Heavy Polypeptide Regulates the Akt-β-Catenin Pathway in Human Esophageal Squamous Cell Carcinoma
por: Kim, Myoung Sook, et al.
Publicado: (2010)

Comparison of Parecoxib and Proparacetamol in Endoscopic Nasal Surgery Patients
por: Leykin, Yigal, et al.
Publicado: (2008)

Effects of Parecoxib and Fentanyl on nociception-induced cortical activity
por: Peng, Yuan-Zhi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_otq1iib9m5i2uk02s3sd6ef2sv